Pan-cancer proteogenomic landscape of whole-genome doubling reveals putative therapeutic targets in various cancer types

Affiliations

• ¹ Department of Integrated Biomedical and Life Science, Korea University, Seoul, Republic of Korea.
• ² L-HOPE Program for Community-Based Total Learning Health Systems, Korea University, Seoul, Republic of Korea.
• ³ Department of Applied Chemistry, Institute of Natural Science, Kyung Hee University, Yongin, Republic of Korea.
• ⁴ Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
• ⁵ Department of Biomedical Science and Technology, Kyung Hee Medical Science Research Institute, Kyung Hee University, Seoul, Republic of Korea.
• ⁶ Department of Biology, Kyung Hee University, Seoul, Republic of Korea.
• ⁷ Department of Biomedical and Pharmaceutical Sciences, Kyung Hee University, Seoul, Republic of Korea.
• ⁸ Department of New Biology, DGIST, Daegu, Republic of Korea.
• ⁹ New Biology Research Center, DGIST, Daegu, Republic of Korea.
• ¹⁰ Center for Cell Fate Reprogramming and Control, DGIST, Daegu, Republic of Korea.
• ¹¹ SG Medical, Inc., Seoul, Republic of Korea.
• ¹² Department of Urology, Cedars-Sinai Medical Center, Los Angeles, California, USA.
• ¹³ Department of Computational Biomedicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.
• ¹⁴ School of Biosystem and Biomedical Science, College of Health Science, Korea University, Seoul, Republic of Korea.